REQUEST A DEMO
Total
USD $0.00
Search more companies

Farma-tek Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farma-tek Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: May 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Farma-Tek Ilac Sanayi Ticaret Ltd.Sti is a Turkish pharmaceutical company. Farma-Tek imports and develops a wide range of medical products, including hemophilia, intensive care, immunoglobulin-containing, dermatology, urology, cardiology, nervous system, nephrology, infection, and surgery products. The company aims to serve the Turkish medical industry by providing quality products regulated by relevant healthcare authorities.

Headquarters
Bayraktar Bulvari No:12 Serif Ali Mahallesi Beyan Sokak Umraniye
Istanbul; Marmara; Postal Code: 34775

Contact Details: Purchase the Farma-tek Ilac A.S. report to view the information.

Website: http://www.farma-tek.com

Basic Information
Total Employees:
Purchase the Farma-tek Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Farma-tek Ilac A.S. report to view the information.
Incorporation Date:
August 28, 1991
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Farma-tek Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
82.7%
Total operating revenue
82.7%
Operating profit (EBIT)
62.79%
Net Profit (Loss) for the Period
20961.91%
Total assets
349%
Total equity
637.35%
Operating Profit Margin (ROS)
-2.77%
Net Profit Margin
12.21%
Return on Equity (ROE)
7%
Debt to Equity Ratio
-61.11%
Quick Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?